# Meta's Prescription Ray-Bans: Stylish but Overpriced

6-week test results of the $499 smart glasses reveal key insights.

- **Source:** [Latest news](https://brifing.si/source/77d15218-219f-472d-bf40-31b5646d2942)
- **Published:** 2026-07-21
- **Topic:** [Business](https://brifing.si/c/business)
- **Original article:** <https://www.zdnet.com/article/meta-ray-ban-blayzer-optics-gen-2-review/>
- **On Brifing:** https://brifing.si/s/c6733da5-ff00-4d71-b897-83b931f885ff

## The era of prescription smart glasses

Blayzer Optics, co-developed by Meta and Ray-Ban, targets prescription users with all-day comfort. Featuring shorter lenses and thick frames, the model starts at $499, positioning itself as a premium product in the smart eyewear market.

## Design and comfort

The tested model offers three nose pad options but falls short for users with high cheekbones. While stylish, the ergonomics don't fully accommodate standard glasses wearers' habits, revealing design limitations.

## Technological upgrades

A secondary raised button adds a customizable third function alongside photo/video capture. The 12MP camera and 3K Ultra HD video capabilities remain unchanged from previous generations.

## Meta AI testing

Library tests showed the AI successfully adding complex calendar events, though limited to Meta's ecosystem. Translation features demonstrated impressive performance in real-world scenarios.

## Battery and charging

While offering 8 hours of audio playback, battery life significantly decreases during photo/video capture. The charging case features a slimmer design compared to earlier models.

## Final verdict

As the first full-day prescription smart glasses, it marks an important milestone. However, the price-to-performance ratio disappoints. The $100 cheaper Wayfarers model emerges as a more reasonable alternative.

## Sources covering this story

- https://www.zdnet.com/article/meta-ray-ban-blayzer-optics-gen-2-review/ — 

---

_Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._
